New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 15 states.
Cannabis sales increased 1.3% sequentially in March, which was a decline on a per-day basis of 8.5%. In this review, we share the results by state, beginning with the western markets and then concluding with the eastern markets. In total, BDSA estimates that sales across the 15 markets totaled $1.99 billion during March, which was down 6.5% from a year ago.
Western Markets
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In March, year-over-year growth was negative in all 5 states, with the annual growth rates ranging from -17.8% in California to -9.4% in Nevada. Growth rose sequentially in three states.
Eastern Markets
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York (medical only), Ohio and Pennsylvania. In March, year-over-year growth ranged from -14.8% in Michigan to +91.2% in Ohio, which began adult-use in August. Note that Florida and Pennsylvania are medical-only markets, and BDSA’s data doesn’t yet capture the adult-use market in New York (which is booming). Sequential growth was negative two markets, and none grew sales on a per-day basis. The annual growth was meager except in two states. Ohio, which legalized for adult-use in August, led the way. We have been warning about Florida potentially slowing despite the strong growth in dispensaries and in unit volumes due to competitive pressure, and this was the first month ever that BDSA projected a decline in sales from a year earlier.
For readers interested in a deeper look at cannabis markets across these fifteen states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with access to actionable data and analysis.
Based in Houston, Alan leverages his experience as founder of online community 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email
New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s monthly cannabis sales data for 15 states.
Cannabis sales increased 1.3% sequentially in March, which was a decline on a per-day basis of 8.5%. In this review, we share the results by state, beginning with the western markets and then concluding with the eastern markets. In total, BDSA estimates that sales across the 15 markets totaled $1.99 billion during March, which was down 6.5% from a year ago.
Western Markets
BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In March, year-over-year growth was negative in all 5 states, with the annual growth rates ranging from -17.8% in California to -9.4% in Nevada. Growth rose sequentially in three states.
Eastern Markets
BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York (medical only), Ohio and Pennsylvania. In March, year-over-year growth ranged from -14.8% in Michigan to +91.2% in Ohio, which began adult-use in August. Note that Florida and Pennsylvania are medical-only markets, and BDSA’s data doesn’t yet capture the adult-use market in New York (which is booming). Sequential growth was negative two markets, and none grew sales on a per-day basis. The annual growth was meager except in two states. Ohio, which legalized for adult-use in August, led the way. We have been warning about Florida potentially slowing despite the strong growth in dispensaries and in unit volumes due to competitive pressure, and this was the first month ever that BDSA projected a decline in sales from a year earlier.
For readers interested in a deeper look at cannabis markets across these fifteen states and more, including segmentation by additional product categories, brand and item detail, longer history, and segmentation by product attributes, learn how BDSA Solutions can provide you with access to actionable data and analysis.
Get Our Sunday Newsletter
In This Article:
Arizona, bdsa, California, cannabis data analytics, Colorado, Florida, Illinois, Maryland, Massachusetts, michigan, Missouri, Nevada, New Jersey, New York, Ohio, Oregon, Pennsylvania
Related News:
Illinois Cannabis Sales Slip Again in February
Another Rough Month in Michigan
Get Ready For More Problems in Florida
A Strong February for Cannabis Sales